Skip to content

Dupixent for Psoriasis: Hope on the Horizon

Discover the innovative and promising role of Dupixent in managing skin conditions, offering hope and relief to those seeking effective solutions.

Explore how this groundbreaking medication may change the landscape of psoriasis care.

What is Dupixent

dupixent for psoriasis 1

Dupixent is a medication used to treat certain inflammatory conditions, specifically for individuals with moderate to severe forms of atopic dermatitis (eczema) and asthma.

It is not a standalone cure for these conditions but can help manage their symptoms. Dupixent is administered through injection and works by targeting specific proteins in the body that contribute to inflammation.

In the case of atopic dermatitis, Dupixent helps reduce itching, redness, and skin inflammation. For asthma, it can help manage symptoms in people with moderate to severe asthma, especially when other medications haven’t provided sufficient relief.

Dupixent is typically prescribed by a healthcare professional and may be used in combination with other treatments as part of a comprehensive management plan for these conditions. It’s important to follow your healthcare provider’s guidance on its use and any potential side effects.

Dupixent in the treatment of psoriasis

Dupixent (dupilumab) had not yet received approval from the U.S. Food and Drug Administration (FDA) for the treatment of psoriasis. However, the use of Dupixent for various inflammatory skin conditions, including psoriasis, was being explored in clinical trials and research studies.

How is Dupixent used

Dupixent is typically used as a subcutaneous injection, which means it is administered under the skin. Here’s a general guide on how Dupixent is used:

  1. Prescription: Dupixent is a prescription medication, so it must be prescribed by a healthcare provider.

  2. Preparation: Your healthcare provider or a nurse will show you how to properly prepare and administer Dupixent. You can use a single-dose pre-filled syringe with a needle shield or a pre-filled pen, depending on your preference and the form provided.

  3. Injection Site: Dupixent is usually injected in the thigh or abdomen. Your healthcare provider will guide you on the specific injection site.

  4. Injection Process: Follow the instructions given by your healthcare provider for the actual injection. This typically involves cleaning the injection site, removing the cap or needle shield, and injecting the medication as directed.

  5. Dosage: The dosage and frequency of Dupixent injections are determined by your healthcare provider based on your medical condition, such as atopic dermatitis, asthma, or other indications.

  6. Consultation: Regular follow-up with your healthcare provider is crucial to monitor your progress, adjust the treatment plan if necessary, and discuss any side effects or concerns.

It’s essential to strictly follow your healthcare provider’s guidance regarding the use of Dupixent. They will provide detailed instructions tailored to your specific condition and needs.

Dupixent side effects

Dupixent, like many medications, can have potential side effects. It’s important to note that not everyone will experience these side effects, and some people may have a different reaction. Common side effects of Dupixent may include:

  1. Injection Site Reactions: You might experience redness, itching, pain, or swelling at the injection site.

  2. Eye Problems: Some people have reported conjunctivitis (pink eye) and other eye issues while using Dupixent.

  3. Cold Symptoms: These can include a runny or stuffy nose, sneezing, and a sore throat.

  4. Headache: Headaches are a relatively common side effect.

  5. Throat Pain: Sore throat or throat pain may occur.

  6. Irritated Skin: In some cases, skin redness and itchiness might worsen, especially in the initial stages of treatment.

  7. Fever: An elevated body temperature can be a side effect in some individuals.

  8. Nasal Polyps: In clinical trials for chronic rhinosinusitis with nasal polyposis, some patients reported an increased occurrence of nasal polyps.

  9. Hypersensitivity Reactions: Although rare, severe allergic reactions can occur. Seek immediate medical attention if you experience symptoms such as difficulty breathing, swelling of the face, lips, or tongue, or severe itching.

  10. Infections: Dupixent can increase the risk of infections, including respiratory infections, so be cautious if you notice symptoms like fever, cough, or difficulty breathing.

It’s crucial to report any side effects to your healthcare provider, as they can help determine whether Dupixent is the right treatment for you and adjust your treatment plan if needed.

The benefits of Dupixent should be weighed against the potential side effects, and your healthcare provider will help you make informed decisions about your treatment.

Will Dupixent ever be approved for psoriasis treatment

While Dupixent has not yet received FDA approval for the treatment of psoriasis, it’s important to note that the development and approval of medications for various medical conditions can change over time as new clinical trials and research are conducted.

To find the most up-to-date information on whether Dupixent has been approved for the treatment of psoriasis, I recommend consulting the U.S. Food and Drug Administration (FDA) website, or speaking with a healthcare provider who can provide you with the latest information on treatment options for psoriasis. They can also discuss other available treatments and potential options for managing psoriasis effectively.

Common Questions

Does Dupixent treat psoriasis

The FDA had not granted approval for Dupixent (dupilumab) to be used in the treatment of psoriasis.

Is Dupixent for eczema or psoriasis

Dupixent is a prescribed medication for adults and children aged 6 months and older who have moderate-to-severe eczema (atopic dermatitis or AD) that remains uncontrolled with topical prescription treatments or cannot use them.

Is psoriasis a side effect of DUPIXENT

Recent reports show the emergence of psoriasis and psoriasiform reactions following dupilumab therapy, revealing a paradoxical cutaneous response associated with biologics.